November 21, 2026 - 04:20

Globant's recent shift to outcome-based pricing has shown promising results, particularly in its impact on gross margins. This new pricing strategy has already lifted gross margins by approximately 10 percentage points, signaling a significant improvement even before revenue from this model fully scales.
Investors should pay close attention to how this approach not only enhances profitability but also aligns with the growing demand for performance-based contracts in the tech industry. As companies increasingly seek measurable outcomes from their partnerships, Globant's proactive stance could position it favorably in a competitive market.
this shift reflects a broader trend in the industry where value-driven pricing models are becoming more prevalent. By focusing on delivering tangible results, Globant is likely to strengthen client relationships and foster long-term loyalty. these developments suggest a positive outlook for investors considering the company's future trajectory.
November 20, 2026 - 02:05
Docusign to Release Third Quarter Financial Results on December 3, 2026Docusign has announced that it will share its financial results for the third quarter of fiscal 2027 after the U.S. markets close on Thursday, December 3, 2026. Following the release, the company...
November 19, 2026 - 01:35
Royal Gold Expands Board with Mining Veteran Harry Kenyon-SlaneyDENVER, November 18, 2026--Royal Gold has taken a significant step in enhancing its leadership by appointing Harry Kenyon-Slaney to its Board of Directors. Kenyon-Slaney brings a wealth of...
November 18, 2026 - 00:46
Ramon.Space Secures $124 Million to Boost Space ComputingRamon.Space has successfully raised $124 million in a Series B funding round aimed at enhancing its onboard computing systems tailored for the space industry. This significant investment will...
November 17, 2026 - 09:36
Harbour BioMed Welcomes Dr. Sanjay Keswani as Neuroscience Scientific AdvisorHarbour BioMed has announced the addition of Dr. Sanjay Keswani to its team as a Scientific Advisor in the field of Neuroscience. Dr. Keswani brings a wealth of experience and expertise, which will...